47th Annual Meeting of the American Society of Clinical Oncology.

Joensuu, H. (Speaker: Keynote)

Activity: Participating in or organising an event typesOrganisation and participation in conferences, workshops, courses, seminars

Description

Twelve vs. 36 months of adjuvant imatinib as treatment of operable GIST with a high risk of recurrence: Final results of a randomized trial (SSGXVIII/AIO).
Period6 Jun 2011
Event typeOther
LocationChigago, United States
Degree of RecognitionInternational